http://www.fool.com/investing/2016/10/25/better-buy-merck-co-inc-vs-abbvie-inc.aspx
http://www.fool.com/investing/2016/10/25/better-buy-merck-co-inc-vs-abbvie-inc.aspx?source=eptfxblnk0000004&utm_campaign=article&utm_medium=feed&utm_source=foxbusiness
http://www.modernhealthcare.com/article/20161025/NEWS/310259972
http://www.dailymail.co.uk/~/article-3872528/index.html
http://nationalhogfarmer.com/business/coulson-joins-merck-animal-health-s-food-animal-marketing-team
http://www.dailymail.co.uk/~/article-3870502/index.html
http://www.brownsvilleherald.com/news/business/article_12307bf8-a315-5161-9471-6565c24fbeb2.html
https://www.thestreet.com/story/13865757/1/after-fda-approval-merck-posts-better-than-expected-earnings.html
http://www.irishtimes.com/business/health-pharma/merck-beats-quarterly-revenue-expectations-1.2842739
http://www.dailypolitical.com/2016/10/25/private-advisor-group-llc-increases-position-in-merck-co-mrk.html
http://www.wsj.com/articles/merck-revenue-and-profit-rise-on-cancer-drugs-vaccines-1477395829
https://www.thestreet.com/story/13865148/1/merck-lifts-full-year-guidance-after-quarterly-forecast-beat.html
http://www.dailymail.co.uk/~/article-3870502/index.html
http://www.dailymail.co.uk/~/article-3870422/index.html
http://www.dailymail.co.uk/~/article-3870462/index.html
http://www.dailymail.co.uk/~/article-3870386/index.html

http://www.4-traders.com//MERCK-CO-INC-13611/news/Merck-Announces-Third-Quarter-2016-Financial-Results-23269457/
https://www.drugs.com/newdrugs/fda-approves-merck-s-keytruda-pembrolizumab-first-line-certain-patients-metastatic-non-small-cell-4449.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA%2BApproves%2BMerck%25E2%2580%2599s%2BKeytruda%2B%2528pembrolizumab%2529%2Bfor%2BFirst-Line%2BTreatment%2Bof%2BCertain%2BPatients%2Bwith%2BMetastatic%2BNon-Small%2BCell%2BLung%2BCancer
https://www.drugs.com/newdrugs/fda-approves-merck-s-zinplava-bezlotoxumab-reduce-recurrence-clostridium-difficile-infection-4448.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA%2BApproves%2BMerck%25E2%2580%2599s%2BZinplava%2B%2528bezlotoxumab%2529%2Bto%2BReduce%2BRecurrence%2Bof%2BClostridium%2Bdifficile%2BInfection
http://www.scotsman.com/business/companies/tech/licensing-deal-to-give-merck-access-to-scots-innovation-1-4267577
http://www.dailypolitical.com/2016/10/24/mu-investments-co-ltd-cuts-stake-in-merck-co-mrk.html
http://www.webbreakingnews.com/2016/10/25/bartlett-co-llc-buys-4169-shares-of-merck-co-mrk.html

http://www.dailyrecord.co.uk/business/business-science-technology/university-edinburgh-agree-licence-deal-9115976
http://www.webbreakingnews.com/2016/10/24/merck-co-mrk-shares-bought-by-first-personal-financial-services.html
http://cocorioko.net/merck-pharmaceutical-company-lauds-sierra-leone-for-best-practice-and-standards-in-pharmaceutical-control/
http://www.pmlive.com/pharma_news/after_delay%2C_merck_gets_us_approval_for_serious_infection_drug_1174395
http://www.pmlive.com/pharma_news/keytruda%2C_opdivo_narrow_tecentriqs_lead_in_bladder_cancer_1174387
http://investingnews.com/daily/life-science-investing/pharmaceutical-investing/merck-fda-approval-zinplava/
http://www.finanznachrichten.de/nachrichten-2016-10/38938523-bmy-s-opdivo-at-the-altar-again-mrk-gets-fda-nod-watch-out-for-oasm-020.htm
http://www.rttnews.com/2705193/bmy-s-opdivo-at-the-altar-again-mrk-gets-fda-nod-watch-out-for-oasm.aspx
http://www.fool.com/investing/2016/10/25/merck-cos-keytruda-is-off-to-the-races.aspx
http://www.medpagetoday.com/HematologyOncology/LungCancer/61012
http://www.marketwatch.com/story/gardasil-propelled-merck-to-a-strong-third-quarter-but-dont-expect-that-to-last-2016-10-25
http://www.4-traders.com//MERCK-CO-INC-13611/news/Merck-Revenue-and-Profit-Rise-on-Cancer-Drugs-Vaccines-Update-23273288/
http://www.njbiz.com/article/20161025/NJBIZ01/161029897/lung-cancer-drug-fuels-merck-sales-growth-in-third-quarter-as-it-tops-earnings-estimates
http://www.news9.com/story/33471360/merck-breezes-past-3q-profit-expectations-raises-forecast
http://www.cbs46.com/story/33471360/merck-breezes-past-3q-profit-expectations-raises-forecast
http://www.wsoctv.com/news/national-news/ap-top-news/merck-beats-street-3q-forecasts/460425723
http://www.businessinsider.com/merck-q3-2016-earnings-2016-10
http://www.canada.com/business/merck+beats+street+forecasts+hikes+2016+profit+forecast/12315808/story.html
http://www.dothaneagle.com/news/ap/business/merck-beats-street-q-forecasts-hikes-profit-forecast/article_6944d340-6a02-54e8-a5be-aa220e8926a1.html
http://abcnews.go.com/Business/wireStory/merck-beats-street-3q-forecasts-43038107
http://federalnewsradio.com/business-news/2016/10/merck-beats-street-3q-forecasts/
http://www.kswo.com/story/33471361/merck-beats-street-3q-forecasts
http://www.4-traders.com//MERCK-CO-INC-13611/news/Merck-Revenue-and-Profit-Rise-on-Cancer-Drugs-Vaccines-23270014/
http://www.centredaily.com/news/business/article110293607.html
http://www.wgmd.com/fda-approves-mercks-lung-cancer-drug-as-first-line-treatment/
http://etfdailynews.com/2016/10/25/merck-boosts-outlook-as-key-cancer-treatment-gets-new-approvals/
http://www.foxnews.com/health/2016/10/25/fda-approves-mercks-lung-cancer-drug-as-first-line-treatment.html
http://www.rttnews.com/2705941/merck-q3-profit-rises-lifts-2016-outlook.aspx
http://beta.financial.de/news/agenturmeldungen/us-pharmakonzern-merck-co-profitiert-von-verkaufsschlagern-prognose-erhoht/
http://www.bloomberg.com/news/articles/2016-10-25/merck-beats-estimates-as-sales-of-gardasil-vaccine-surge
http://www.pmlive.com/pharma_news/merck_gets_early_ok_for_keytruda_in_first-line_lung_cancer_1174514
http://www.canadianbusiness.com/business-news/merck-beats-street-3q-forecasts/
http://www.finanznachrichten.de/nachrichten-2016-10/38956776-merck-co-inc-reports-10-increase-in-q3-profit-020.htm
http://www.4-traders.com//MERCK-CO-INC-13611/news/Merck-beats-Street-3Q-forecasts-23269553/
https://www.drugs.com/clinical_trials/merck-announces-pivotal-phase-3-study-letermovir-met-primary-endpoint-17212.html?utm_source=ddc&utm_medium=rss&utm_campaign=Merck%2BAnnounces%2BPivotal%2BPhase%2B3%2BStudy%2Bof%2BLetermovir%2BMet%2BPrimary%2BEndpoint
http://www.4-traders.com//GLAXOSMITHKLINE-PLC-9590199/news/GlaxoSmithKline-files-for-regulatory-approval-of-its-shingles-vaccine-for-adults-50-and-older-23266971/
http://www.marketwatch.com/story/these-investors-many-with-religious-ties-are-calling-for-drug-price-transparency-2016-10-24
http://247wallst.com/healthcare-business/2016/10/24/what-to-expect-from-merck-earnings-3/
http://www.wsj.com/articles/faith-based-investor-group-calls-for-drugmakers-to-be-transparent-on-pricing-1477317600
http://www.bloomberg.com/news/articles/2016-10-24/glaxo-seeks-approval-in-u-s-for-experimental-shingles-vaccine
https://pjmedia.com/instapundit/247255/
http://abcnews.go.com/Business/wireStory/business-highlights-43055565
http://www.canadianbusiness.com/business-news/business-highlights-868/
http://www.startribune.com/business-highlights/398502151/
http://www.msn.com/en-us/money/markets/stocks-close-lower-on-mixed-earnings-results/ar-AAjnpa3?srcref=rss
http://www.dailymail.co.uk/~/article-3872420/index.html
http://www.4-traders.com//news/MARKET-SNAPSHOT-Stock-Market-Heads-Lower-After-Mixed-Earnings-Consumer-confidence-Drop--23273566/
http://www.4-traders.com//news/MARKET-SNAPSHOT-Stock-Market-Heads-Lower-After-Mixed-Earnings-Consumer-confidence-Drop--23273476/
http://finance.yahoo.com/news/global-stocks-commodities-climb-economic-confidence-lifts-090751537--finance.html
http://www.benzinga.com/news/earnings/16/10/8598230/epic-earnings-many-us-companies-beating-expectations-as-season-continues
http://www.dailymail.co.uk/~/article-3870734/index.html
https://uk.news.yahoo.com/japan-shares-hit-six-month-high-u-dollar-012746788--finance.html
https://uk.finance.yahoo.com/news/global-markets-stocks-commodities-climb-122031162.html
http://www.actionnewsjax.com/news/merck-beats-street-3q-forecasts/460426485
http://www.pmlive.com/pharma_news/gsks_blockbuster_hopeful_shingrix_filed_in_us_1174505
http://www.irishtimes.com/news/science/department-of-health-urges-parents-to-ensure-their-daughters-receive-the-hpv-cervical-cancer-vaccine-1.2836689
http://satprnews.com/2016/10/25/big-pharma-focus-on-building-patent-portfolio-to-gain-competitive-edge-in-biologics-sector-2/
http://www.emailwire.com/release/289077-Anti-Aging-Products-and-Therapies-Global-Market-Outlook-20152022.html
http://www.mmm-online.com/pipeline/new-science-drives-biopharma-interest-in-neurological-conditions/article/567826/
http://www.irishexaminer.com/business/glaxosmithklineseeks-shingles-vaccine-427398.html
http://www.marketwatch.com/story/agilent-technologies-receives-expanded-fda-approval-for-use-of-dako-pd-l1-ihc-22c3-pharmdx-companion-diagnostic-in-non-small-cell-lung-cancer-nsclc-2016-10-24
http://www.4-traders.com//AGILENT-TECHNOLOGIES-INC-11488/news/Agilent-Technologies-Receives-Expanded-FDA-Approval-for-Use-of-Dako-PD-L1-IHC-22C3-pharmDx-Compani-23266907/

http://www.mmm-online.com/roundup/five-things-for-pharma-marketers-to-know-monday-october-24-2016/article/567652/
http://etfdailynews.com/2016/10/24/are-health-care-etfs-a-buy-heading-into-earnings-season/
http://www.marketwatch.com/story/gradalis-announces-the-appointment-of-dr-brian-daniels-to-the-newly-formed-scientific-advisory-board-2016-10-24
http://www.prnewswire.com/news-releases/gradalis-announces-the-appointment-of-dr-brian-daniels-to-the-newly-formed-scientific-advisory-board-300349786.html
http://www.cnbc.com/2016/10/24/gsk-files-potential-1-billion-shingles-vaccine-for-us-approval.html
http://uk.reuters.com/article/uk-gsk-shingles-idUKKCN12O0JR
http://www.thehindubusinessline.com/news/world/gsk-files-1-b-shingles-vaccine-for-us-approval/article9262152.ece
http://www.prnewswire.com/news-releases/the-launch-of-mercks-letermovir-for-cytomegalovirus-will-transform-the-treatment-paradigm-for-transplant-recipients-while-the-availability-of-a-new-prophylactic-vaccine-and-antibody-will-drive-growth-in-the-respiratory-syncytial-300343407.html
http://wraltechwire.com/gsk-seeks-us-approval-for-blockbuster-shingles-vaccine/16154046/
http://www.staradvertiser.com/2016/10/24/business/calendar-business/business-calendar-31/
http://federalnewsradio.com/business-news/2016/10/update-on-the-latest-in-business-337/
http://www.dailymail.co.uk/~/article-3866178/index.html
http://www.livetradingnews.com/week-ahead-wall-street-13-19601.html
http://www.marketwatch.com/story/us-stocks-close-lower-as-earnings-data-weigh-2016-10-25
http://www.4-traders.com//news/Humira-Biosimilars-Clinical-Trial-Insight-Report-2016-Patent-Litigation-Issues-Involving-Developmen--23273459/
http://www.finanznachrichten.de/nachrichten-2016-10/38963013-global-humira-adalimumab-biosimilars-clinical-trial-insight-report-2016-humira-had-topped-us-dollar-14-billion-of-sales-globally-research-and-markets-008.htm
http://www.prnewswire.com/news-releases/asthma-and-copd-drugs-market-is-expected-to-reach-50359-million-globally-by-2022---allied-market-research-598367331.html
http://www.finanznachrichten.de/nachrichten-2016-10/38961359-asthma-and-copd-drugs-market-is-expected-to-reach-dollar-50-359-million-globally-by-2022-allied-market-research-008.htm
http://www.marketwatch.com/story/asthma-and-copd-drugs-market-is-expected-to-reach-50359-million-globally-by-2022---allied-market-research-2016-10-25
http://www.prnewswire.co.uk/news-releases/asthma-and-copd-drugs-market-is-expected-to-reach-50359-million-globally-by-2022---allied-market-research-598367301.html
http://www.shopfloor.org/2016/10/tpp-in-real-life-from-bagel-baskets-to-highly-engineered-industrial-products-why-one-baltimore-based-small-business-says-we-need-to-pass-tpp-and-export-like-crazy/
http://www.wiwo.de/unternehmen/industrie/merckundco-us-pharmakonzern-profitiert-von-neuem-krebsmittel/14737566.html
http://www.handelsblatt.com/unternehmen/industrie/merckundco-us-pharmakonzern-profitiert-von-neuem-krebsmittel/14736944.html
http://www.finanznachrichten.de/nachrichten-2016-10/38959601-prescription-pharmaceuticals-market-worth-usd-918-74-billion-by-2020-scalar-market-research-008.htm
http://www.fool.com/investing/2016/10/25/4-top-drug-stocks-that-can-be-purchased-on-the-che.aspx?source=eptfxblnk0000004&utm_campaign=article&utm_medium=feed&utm_source=foxbusiness
http://www.foxnews.com/health/2016/10/25/cancer-made-me-broke.html
http://www.fool.com/investing/2016/10/25/4-top-drug-stocks-that-can-be-purchased-on-the-che.aspx
http://www.prnewswire.com/news-releases/big-pharma-focus-on-building-patent-portfolio-to-gain-competitive-edge-in-biologics-sector-300350468.html
http://www.finanznachrichten.de/nachrichten-2016-10/38955596-big-pharma-focus-on-building-patent-portfolio-to-gain-competitive-edge-in-biologics-sector-008.htm
http://www.prnewswire.co.uk/news-releases/big-pharma-focus-on-building-patent-portfolio-to-gain-competitive-edge-in-biologics-sector-598312001.html
http://www.rttnews.com/2705782/ino-slips-on-clinical-hold-mrk-gets-fda-nod-be-all-ears-for-akao.aspx
http://www.finanznachrichten.de/nachrichten-2016-10/38954032-ino-slips-on-clinical-hold-mrk-gets-fda-nod-be-all-ears-for-akao-020.htm
http://www.spokesman.com/stories/2016/oct/25/advisory-panel-recommends-just-two-hpv-vaccine-dos/
http://www.pr.com/press-release/692593
http://www.mmm-online.com/legalregulatory/jj-exec-calls-california-pricing-measure-misguided/article/567654/
http://www.khaleejtimes.com/nation/dubai/rising-to-the-occasion-is-key-to-success-say-women-leaders
http://investingnews.com/daily/life-science-investing/pharmaceutical-investing/ligand-partner-melinta-therapeutics-baxdela-new-drug-application/
http://www.emailwire.com/release/288235--Hypercholesterolemia-Drugs-Market-2016-Trend-Analysis-and-Overview.html

http://www.marketwatch.com/story/ligand-partner-melinta-therapeutics-submits-baxdela-new-drug-application-for-hospital-treated-skin-infections-2016-10-24

http://www.ibtimes.co.uk/glaxosmithkline-seeks-fda-approval-shingles-vaccine-1587943
http://www.dailymail.co.uk/~/article-3866046/index.html
http://www.wmbfnews.com/story/33456280/police-3-men-facing-felony-charges-after-assaulting-juveniles-in-easley-home

http://www.kiplinger.com/article/investing/T052-C007-S001-why-you-should-invest-in-health-care-stocks-now.html
http://www.cityam.com/252202/before-bell-you-need-know-before-us-market-open
http://www.4-traders.com//news/Global-Esophageal-Cancer-Therapeutics-Report-2016-Pipeline-Review-of-52-Companies-76-Drug-Molecul--23266153/



